NATURES SUNSHINE PRODUCTS INC
For the period ended Dec 31, 2023. Filed Mar 12, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 12, 2024
NATR$10.93-0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
| (a)(1) | List of Financial Statements |
|---|---|
| The following are filed as part of this report: | |
| Report of Independent Registered Public Accounting Firm | |
| Consolidated balance sheets as of December 31, 2023 and 2022 | |
| Consolidated statements of operations for the years ended December 31, 2023 and 2022 | |
| Consolidated statements of comprehensive income for the years ended December 31, 2023 and 2022 | |
| Consolidated statements of changes in shareholders’ equity for the years ended December 31, 2023 and 2022 | |
| Consolidated statements of cash flows for the years ended December 31, 2023 and 2022 | |
| Notes to consolidated financial statements | |
| (a)(2) | List of Financial Statement Schedules |
| Schedule II - Valuation and Qualifying Accounts. | |
| Financial statement schedules other than the one listed are omitted for the reason that they are not required or are not applicable, or the required information is shown in the financial statements or notes thereto, or contained elsewhere in this report. | |
| (a)(3) | List of Exhibits |
| Exhibit Index as seen below |
LIST OF EXHIBITS
| Item No. | Exhibit |
| 3.1(1) | Amended and Restated Articles of Incorporation. |
| 3.2(2) | Amended and Restated Bylaws, dated March 8, 2021. |
| 4.1 (3) | Description of Capital Stock of Nature’s Sunshine Products, Inc. |
| 10.1(4)* | Tax Deferred Retirement Plan, Restated January 1, 2012. |
| 10.2(5)* | Supplemental Elective Deferral Plan, as Amended effective as of January 1, 2008. |
| 10.3 (6)* | Form of Award Agreement (2012 Stock Incentive Plan). |
| 10.4 (7)* | Executive Agreement, dated September 14, 2018, between the Company and Terrence Moorehead. |
| 10.5 (8)* | Amendment to Executive Agreement, dated October 19, 2018, between the Company and Terrence Moorehead. |
| 10.6 (9)* | Stockholder Agreement dated June 26, 2014, between Nature’s Sunshine Products, Inc. and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
| 10.7 (10) | Amendment to Operating Agreement |
| 10.8 (11) | Operating Agreement dated August 25, 2014, among Nature’s Sunshine Products, Inc., Fosun Industrial Co., Limited and Nature’s Sunshine Hong Kong Limited. |
| 10.9 (12) | Amended and Restated 2012 Stock Incentive Plan |
| 10.10 (13) | Loan Agreement dated July 11, 2017, between Bank of America, N.A. and Nature’s Sunshine Products, Inc. |
| 10.11 (14) | Amendment No. 4 to Loan Agreement |
| 10.12 (15) | Form of Restricted Stock Unit Award Agreement |
| 10.13 (16) | Form of Performance Share Unit Award Agreement |
| 10.14 (17) | Employment Agreement dated December 30, 2022 between Shane Jones and Nature’s Sunshine Products, Inc. |
| 10.15 (18) | Employment Agreement dated May 16, 2022 between Martin Gonzalez and Nature’s Sunshine Products, Inc. |
| 21(19) | List of Subsidiaries of Registrant. |
| 23.1(19) | Consent of Independent Registered Public Accounting Firm. |
| 31.1(19) | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2(19) | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.3(19) | Certification of Chief Accounting Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1(19) | Certification of Chief Executive Officer pursuant to 18 U.S.C. § 1350. |
| 32.2(19) | Certification of Chief Financial Officer pursuant to 18 U.S.C. § 1350. |
| 32.3(19) | Certification of Chief Accounting Officer pursuant to 18 U.S.C. § 1350. |
| 97(19) | Nature’s Sunshine Products, Inc. Incentive Compensation Recovery Policy |
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 104 | Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| (1) | Previously filed as Exhibit 3.1 to the Annual Report on Form 10-K filed on March 16, 2018, and is incorporated herein by reference. |
| (2) | Previously filed as Exhibit 3.2 to the Current Report on Form 8-K filed on March 11, 2021, and is incorporated herein by reference. |
| (3) | Previously filed as Exhibit 4.1 to the Annual Report on Form 10-K/A filed on July 9, 2021, and is incorporated herein by reference. |
| (4) | Previously filed as Exhibit 10.1 to the Annual Report on Form 10-K filed on March 13, 2015, and is incorporated herein by reference. |
| (5) | Previously filed as Exhibit 10.2 to the Annual Report on Form 10-K filed on March 14, 2016, and is incorporated herein by reference. |
| (6) | Previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed on January 15, 2015, and is incorporated herein by reference. |
| (7) | Previously filed as Exhibit 10.3 to the Current Report on Form 8-K filed on September 26, 2018, and is incorporated herein by reference. |
| (8) | Previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed on October 24, 2018, and is incorporated herein by reference. |
| (9) | Previously filed as Exhibit 10.2 to the Current Report on Form 8-K filed on July 2, 2014, and is incorporated herein by reference. |
| (10) | Previously filed as Exhibit 99.1 to the Current Report on Form 8-K filed on August 17, 2021, and is incorporated herein by reference. |
| (11) | Previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed on August 29, 2014, and is incorporated herein by reference. |
| (12) | Included as Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A file on March 19, 2021, and incorporated herein by reference. |
| (13) | Previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed on June 16, 2020, and is incorporated herein by reference. |
| (14) | Previously filed as Exhibit 10.2 to the Current Report on Form 8-K filed on June 28, 2022, and is incorporated herein by reference. |
| (15) | Previously filed as an Exhibit to the Quarterly Report on Form 10-Q filed on August 9, 2022, and is incorporated herein by reference. |
| (16) | Previously filed as an Exhibit to the Quarterly Report on Form 10-Q filed on November 3, 2022, and is incorporated herein by reference. |
| (17) | Previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed on December 7, 2022, and is incorporated herein by reference. |
| (18) | Previously filed as Exhibit 10.19 to the Annual Report on Form 10-K filed on March 16, 2023, and is incorporated herein by reference. |
| (19) | Filed herewith. |
| * | Management contract or compensatory plan. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.